TVARDI THERAPEUTICS O.N.

Share · US1407553072 · TVRD · A414VY (XNCM)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

03.02.2026 21:00

Current Prices from TVARDI THERAPEUTICS O.N.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	TVRD	USD	03.02.2026 21:00	3,95 USD	-0,04 USD -1,00 %

Share Float & Liquidity

Free Float 66,74 %

Shares Float 6,26 M

Shares Outstanding 9,38 M

Company Profile for TVARDI THERAPEUTICS O.N. Share

Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. Their lead candidate, TTI-101, is currently in Phase 2 clinical trials for idiopathic pulmonary fibrosis (IPF) and hepatocellular carcinoma (HCC).

AI Analysis of TVARDI THERAPEUTICS O.N.

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of TVARDI THERAPEUTICS O.N.

No AI threads available for this company yet.

Company Data

Name TVARDI THERAPEUTICS O.N.

Company Tvardi Therapeutics, Inc.

Symbol TVRD

Website https://www.caratherapeutics.com

Primary Exchange

Frankfurt

WKN A414VY

ISIN US1407553072

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Imran Alibhai

Country United States of America

Currency EUR

Employees 0,0 T

Address 2450 Holcombe Blvd, Suite X, 77021 Sugar Land

IPO Date 2025-04-16

Stock Splits

Date	Split
16.04.2025	1:3

ID Changes

Date	From	To
16.04.2025	CARA	TVRD

Ticker Symbols

Name	Symbol
NASDAQ	TVRD

More Shares

Investors who hold TVARDI THERAPEUTICS O.N. also have the following shares in their portfolio:

Harding Loevner Emerging Markets Portfolio Advisor Class Fund

RELX CAPITAL 25/30 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog